Tetra Radar · FDA Approvals · Decision date
piflufolastat: FDA decision date
Lantheus Holdings Inc (LNTH) · 6 March 2026
In August 2025, we announced that the FDA had accepted our New Drug Application (“NDA”) for a new formulation of our F-18 PSMA PET imaging agent, filed by our subsidiary Aphelion, and that the FDA has set a Prescription Drug User Fee Act (“PDUFA”) target action date of March 6, 2026.
Source: 10-K of 26 February 2026
The date has passed; Tetra Radar has not recorded an approval.
Lantheus Holdings Inc on Tetra Radar
A PDUFA date is the date by which the FDA has said it will decide on an application. Dates can move, and a decision is not an approval. Tetra Radar observes public information for research purposes. It does not provide investment advice.